Leukaemia & Lymphoma Research is investing more than £7 million in clinical trials which are improving treatments for patients with blood cancer across the UK.
Clinical trials test new drugs and treatments, or combinations of these in patients. These are vital for moving breakthroughs discovered in the laboratory onto hospital wards to treat patients - without clinical trials, we wouldn't be able to make the progress we have done in beating blood cancer.
We're currently committed to a range of trials involving adults and children with leukaemia, lymphoma and myeloma. We also invest in clinical studies that investigate interesting aspects of clinical trials as well as pay for support staff including research nurses.
Find out more about what it means to take part in a clinical trial.
Our Trials Acceleration Programme
Crucially, we've launched a unique network of clinical trials centres, which will give blood cancer patients access to new life-saving drugs, sooner and improve survival rates.
This initiative is called the Trials Acceleration Programme. It's an innovative clinical trials network that links 13 leading hospitals in the UK means that patients have access to cutting edge treatments at their local hospital, more quickly.
It's already having a massive impact and attracting interest from people who want to learn from this innovative model.